LBLeif Bostad

Leif Bostad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Leif Bostad has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diagnostic yield of biopsies of cervical lymph nodes using a large (14‐gauge) core biopsy needle

    by Ole M. Pedersen, Hans J. Aarstad, Turid Løkeland, Leif Bostad

    The purpose of this study was to assess retrospectively complications and diagnostic yield of core needle biopsy (CNB) of cervical lymph nodes using 14‐gauge as sole needle bore. During a 10‐year period ultrasound (US)‐guided CNB, using a 14‐gauge Tru‐Cut needle (non‐advancing), was performed in 140 consecutive cases (135 patients, aged 8–88 years) when a detailed histological diagnosis was required to guide therapy. CNB findings were consistent with the final diagnosis in 129 of the 140 cases, comprising 36 benign lesions, 40 metastases, and 53 lymphomas (40 NHL and 13 HL) of which subclassification (WHO criteria) was partial in 5NHL, and complete in 35 (87.5%) NHL and 13 HL (100%), including all 7 lymphomatous nodes with short‐axis diameter ≤1.0 cm. Two lymphomas were falsely interpreted as reactive hyperplasia. Nine samples (6.4%) were inadequate for histopathological analysis. One patient experienced pain in an arm lasting 3–4 days. No other immediate or delayed complications were diagnosed. A 14‐gauge may be used safely as the sole needle bore in US‐guided CNB of cervical lymph nodes, rendering samples sufficient for full subtyping in lymphoma, even in the smallest nodes.


  • Open Access

    The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-segment elevation myocardial infarction: a brief communication

    by Trygve Brugger-Andersen, Leif Bostad, Dagny Ann Sandnes, Alf Inge Larsen, Vernon Vs Bonarjee, Stale Barvik, Tor Melberg, Dennis Wt Nilsen

    The expression of pregnancy-associated plasma protein A (PAPP-A) was identified by immunohistochemistry (IHC) in culprit atherothrombotic plaque specimens harvested from patients admitted with ST-segment elevation myocardial infarction (STEMI).


  • Open Access

    pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda

    by Sam Kalungi, Solrun J Steine, Henry Wabinga, Leif Bostad, Anders Molven

    Background: The members of the retinoblastoma protein family, pRb, p107 and pRb2 (p130), are central players in controlling the cell cycle. Whereas disturbed function of pRb is commonly seen in human cancers, it is still an open question whether pRb2 is involved in tumorigenic processes. However, altered subcellular localization of pRb2 and mutations in the pRb2-encoding gene RBL2 have been described for some tumours, including Burkitt lymphomas (BL). Methods: We retrieved 51 biopsy specimens of endemic BL cases from Uganda. The expression of pRb2 was determined by immunohistochemistry. Exons 19-22 of the RBL2 gene, the region known to contain a nuclear localization signal, were screened for mutations by PCR amplification and direct DNA sequencing. Results: Nearly all of our cases (84.0%) were positive for pRb2 protein expression although this protein is a marker for growth arrest and Burkitt lymphoma is characterized by a high proliferation rate. Of the positive cases, 73.8% were scored as expressing the protein at a high level. Subcellular pRb2 localization was predominantly nuclear and no cases with expression restricted to the cytoplasm were observed. We did not detect any RBL2 mutations in the part of the gene that encodes the C-terminal end of the protein. Conclusion: The majority of endemic BL cases from Uganda express pRb2, but somatic RBL2 mutations affecting the protein's nuclear localization signal appear to be rare.